ライフサイエンスコーパス: sleep apnea syndrome

1 thmatics with moderate to severe obstructive sleep apnea syndrome.

2 tients, 697 (68 percent) had the obstructive sleep apnea syndrome.

3 s and sleep in patients with the obstructive sleep apnea syndrome.

4 important in the pathogenesis of obstructive sleep apnea syndrome.

5 ic cardiovascular abnormality in obstructive sleep apnea syndrome.

6 l occlusion which results in the obstructive sleep apnea syndrome.

7 been tested as pharmacologic treatments for sleep apnea syndrome.

8 he ratio of %EFV to %VAF loss decreased with sleep apnea syndrome (1.34+/-0.3 vs. 0.52+/-0.08, p<0.05

9 ously regarding the evolution of obstructive sleep apnea syndrome and persistence of abnormal pharyng

10 d disorders of ventilatory control including sleep apnea syndromes and obesity hypoventilation syndro

11 s included obesity hypoventilation syndrome, sleep apnea syndrome, hypertension, gastroesophageal ref

12 fficient condition for the production of the sleep apnea syndrome in normal individuals.

13 rved a significant prevalence of obstructive sleep apnea syndrome in patients in waiting list for LT,

14 ting, surgical treatment for the obstructive sleep apnea syndrome in school-age children did not sign

15 and nine patients with untreated obstructive sleep apnea syndrome in wakefulness and sleep.

16 Obstructive sleep apnea syndrome involves abnormal upper airway sens

17 Obstructive sleep apnea syndrome is a highly prevalent disease resul

18 Obstructive sleep apnea syndrome is a well recognized cause of exces

19 gs confirm previous reports that obstructive sleep apnea syndrome is associated with reduced parasymp

20 Sleep apnea syndrome is one of a series of sleep-related

21 ered breathing, particularly the obstructive sleep apnea syndrome, is common during childhood.

22 studies have suggested that the obstructive sleep apnea syndrome may be an important risk factor for

23 ions of these findings for the management of sleep apnea syndrome must be verified by appropriate cli

24 ne the independent effect of the obstructive sleep apnea syndrome on the composite outcome of stroke

25 ity (body mass index [BMI] >35), obstructive sleep apnea syndrome, or other causes of respiratory fai

26 Many patients with obstructive sleep apnea syndrome (OSA) living near sea level travel

27 ARS) (23%) than in subjects with obstructive sleep apnea syndrome (OSAS) (0.06%), parasomnia (0.7%),

28 ight is modestly associated with obstructive sleep apnea syndrome (OSAS) among young children, but st

29 Obstructive sleep apnea syndrome (OSAS) and nonalcoholic fatty liver

30 ittent hypoxia (CIH) occurs with obstructive sleep apnea syndrome (OSAS) and provokes systemic endoth

31 ative treatment in children with obstructive sleep apnea syndrome (OSAS) associated with significant

32 Children with obstructive sleep apnea syndrome (OSAS) have more collapsible airway

33 he upper airway in children with obstructive sleep apnea syndrome (OSAS) have not been established.

34 The prevalence of obstructive sleep apnea syndrome (OSAS) in patients with nonarteriti

35 The obstructive sleep apnea syndrome (OSAS) is associated with cardiovas

36 Obstructive sleep apnea syndrome (OSAS) is associated with intermitt

37 the pathophysiology of pediatric obstructive sleep apnea syndrome (OSAS) is suggested by the observat

38 Obstructive sleep apnea syndrome (OSAS) is usually diagnosed with ov

39 Obstructive sleep apnea syndrome (OSAS) leads to neurocognitive and

40 few studies suggesting that the obstructive sleep apnea syndrome (OSAS) may compromise optic nerve h

41 estigate the correlation between obstructive sleep apnea syndrome (OSAS) risk with periodontal diseas

42 asthma patients with concomitant obstructive sleep apnea syndrome (OSAS) seems to have a favorable im

43 Obstructive sleep apnea syndrome (OSAS), a disorder characterized by

44 s been reported in patients with obstructive sleep apnea syndrome (OSAS), and these two chronic condi

45 s a role in treating snoring and obstructive sleep apnea syndrome (OSAS).

46 ocampus-dependent cognition, and obstructive sleep apnea syndrome (OSAS).

47 tematically in children with the obstructive sleep apnea syndrome (OSAS).

48 way pressure (CPAP) titration in obstructive sleep apnea syndrome (OSAS).

49 al breathing in 10 children with obstructive sleep apnea syndrome (OSAS; age, 4.3 +/- 2.3 years) and

50 ent (Mallampati score III or IV, obstructive sleep apnea syndrome, reduced mobility of cervical spine

51 rillation, and hypertension, the obstructive sleep apnea syndrome retained a statistically significan

52 syndrome (FES) and body mass index (BMI) in sleep apnea syndrome (SAS) patients compared to normal s

53 eart disease, morbid obesity associated with sleep apnea syndrome, sickle cell disease, and polycythe

54 The obstructive sleep apnea syndrome significantly increases the risk of

55 n, 5 to 9 years of age, with the obstructive sleep apnea syndrome to early adenotonsillectomy or a st

56 Prevalence of obstructive sleep apnea syndrome was 38% before the LT, 86% at 6 mon

57 In an unadjusted analysis, the obstructive sleep apnea syndrome was associated with stroke or death

58 The diagnosis of the obstructive sleep apnea syndrome was based on an apnea-hypopnea inde

59 sized that, in children with the obstructive sleep apnea syndrome without prolonged oxyhemoglobin des

60 y performed in children with the obstructive sleep apnea syndrome, yet its usefulness in reducing sym